ENTITY
Kolon TissueGene

Kolon TissueGene (950160 KS)

13
Analysis
Health CareUnited States
Kolon TissueGene, Inc. operates as a biopharmaceutical company. The Company develops novel advanced orthopedic disorders cell therapies, novel cell and gene therapies drugs, and other related products. Kolon TissueGene offers services worldwide.
more
25 Nov 2017 21:53

Summary of KOSDAQ 150 December Reshuffle & Rebalancing

It was officially announced that a total of 13 stocks would be newly added to KOSDAQ 150 in the upcoming periodical reshuffle, whereas the same...

Logo
508 Views
Share
16 Nov 2017 22:57

KOSDAQ's Bullish Run - Main Drivers & Stocks to Pick

KOSDAQ is getting really hot. Over the past three months, KOSDAQ index climbed 22.89% by 145.31 points from 642.11 on Aug 17 to 780.22 today on Nov...

Logo
638 Views
Share
bearishCJ ENM
10 Nov 2017 22:06

CJ E&M Vs. Hanjin Kal - Trade Pattern Analysis Amid Subsidiary IPO

We, Korea, have two major IPOs coming up late this year. They are Studio Dragon Corp (253450 KS) and Jin Air Co., Ltd. (272450 KS). Both are...

Logo
255 Views
Share
07 Nov 2017 02:29

TissueGene IPO Part 5 - Recap on First Day Trade

TissueGene Inc. (950160 KS)'s opening price was set at ₩52,000. Well, this is a whopping 92.6% up from the IPO price of ₩27,000. Eventually, it...

Logo
262 Views
Share
19 Oct 2017 22:51

TissueGene IPO Part 4 - Bookbuilding Result Review

Can you believe this?TissueGene Inc. (950160 KS) IPO price was set at ₩27,000. This is the upper end of the indicative price band, ₩16,000 -...

Logo
262 Views
Share
x